Six‐gene Assay as a new biomarker in the blood of patients with colorectal cancer: establishment and clinical validation

Colorectal cancer (CRC) is the second most common cancer in men and the third most common cancer in women. Although long‐term survival has improved over the past 30 years, at least 50% of patients with CRC will develop metastases after diagnosis. In this study, we examined whether quantifying the mR...

Descripción completa

Detalles Bibliográficos
Autores principales: Shou, Xin, Li, Yong, Hu, Weilei, Ye, Tingting, Wang, Guosheng, Xu, Feng, Sui, Meihua, Xu, Yibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441906/
https://www.ncbi.nlm.nih.gov/pubmed/30556647
http://dx.doi.org/10.1002/1878-0261.12427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441906/
https://www.ncbi.nlm.nih.gov/pubmed/30556647
http://dx.doi.org/10.1002/1878-0261.12427

Ejemplares similares